Contact: Nutra Pharma Corp. Nina Goldstein 877-895-5647 IR@nutrapharma.com Nutra Pharma is announcing today the first of several restructuring steps that will expand the Company’s core business strengths, restructure debt as well as increase its reach into important commercial markets. March 8, 2018 -- Coral Springs, Florida -- Nutra Pharma Corporation (OTC: NPHC), a biotechnology company developing drugs for the treatment of Multiple Sclerosis (MS) and HIV and that also mark